Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders
NCT00968461
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Conditions
Leukemia
Lymphoproliferative Disorders
Interventions
DRUG:
Phenethyl Isothiocyanate (PEITC)
Sponsor
M.D. Anderson Cancer Center